PubRank
Search
About
Central Obesity and Disease Risk in Japanese Americans
Clinical Trial ID NCT00005365
PubWeight™ 0.00
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT00005365
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study.
Diabetes Care
1999
2.25
2
Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men.
Diabetes Care
1995
1.44
3
Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans.
Diabetes Care
1999
1.26
4
Susceptibility to development of central adiposity among populations.
Obes Res
1995
1.15
5
Diabetes and diabetes risk factors in second- and third-generation Japanese Americans in Seattle, Washington.
Diabetes Res Clin Pract
1994
1.07
6
Low serum testosterone level as a predictor of increased visceral fat in Japanese-American men.
Int J Obes Relat Metab Disord
2000
1.00
7
Visceral adiposity, fasting plasma insulin, and blood pressure in Japanese-Americans.
Diabetes Care
1995
0.94
8
Low insulin secretion and high fasting insulin and C-peptide levels predict increased visceral adiposity. 5-year follow-up among initially nondiabetic Japanese-American men.
Diabetes
1996
0.90
9
Increased plasma leptin levels are associated with fat accumulation in Japanese Americans.
Diabetes
1998
0.89
10
Visceral adiposity, fasting plasma insulin, and lipid and lipoprotein levels in Japanese Americans.
Int J Obes Relat Metab Disord
1996
0.88
11
Effect of regional fat distribution and Prader-Willi syndrome on plasma leptin levels.
J Clin Endocrinol Metab
1997
0.83
12
Hypertension in Japanese Americans: the Seattle Japanese-American Community Diabetes Study.
Public Health Rep
1996
0.78
13
Fasting insulin level underestimates risk of non-insulin-dependent diabetes mellitus due to confounding by insulin secretion.
Am J Epidemiol
1997
0.77
Next 100